U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H28FN3O2
Molecular Weight 409.4964
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MESPIPERONE

SMILES

CN1CN(C2=CC=CC=C2)C3(CCN(CCCC(=O)C4=CC=C(F)C=C4)CC3)C1=O

InChI

InChIKey=QHJLPOSPWKZACG-UHFFFAOYSA-N
InChI=1S/C24H28FN3O2/c1-26-18-28(21-6-3-2-4-7-21)24(23(26)30)13-16-27(17-14-24)15-5-8-22(29)19-9-11-20(25)12-10-19/h2-4,6-7,9-12H,5,8,13-18H2,1H3

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24737115 | https://www.ncbi.nlm.nih.gov/pubmed/24848155 | https://www.ncbi.nlm.nih.gov/pubmed/1531364 | https://www.ncbi.nlm.nih.gov/pubmed/11313155 | https://www.ncbi.nlm.nih.gov/pubmed/10360125

N-Methylspiperone (NMSP) is a derivate of spiperone and high-affinity D2/3 dopamine and 5-HT2A serotonin receptor antagonist. In the biodistribution studies in rodents, there was a high accumulation of radioactivity in the liver, lung, and kidneys, whereas the brain radioactivity was not as high N-Methylspiperone is used to study the dopamine and serotonin neurotransmitter systems. Labeled with the radioisotope carbon-11, it can be used for positron emission tomography (PET). [11C] N-Methylspiperone PET is useful for objective monitoring of D2and 5-HT2A receptor occupancy and density in patients being treated with antipsychotic drugs.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.133 nM [Ki]
0.265 nM [Ki]
0.55 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Imaging dopamine receptors in the human brain by positron tomography.
1983 Sep 23
Patents

Patents

Sample Use Guides

11C-NMSP PET studies were taken 40 min after a bolus i.v. injection of approximately 20 mCi 11C-NMSP. To create the normal 11C-NMSP SPM image template, additional dynamic scans were obtained at 0–60 min after injection of 11C-NMSP under the resting state in healthy controls.
Route of Administration: Intravenous
HEK293 cells stably expressing human dopamine D2 and D3 receptors were used for activity evaluation. Immediately prior to testing, N-Methylspiperone was freshly dissolved in 30% DMSO and 70% H2O to a stock concentration of 100 μM and diluted into 13 half-log serial dilutions using 30% DMSO vehicle. Final test concentrations ranged from 10 μM to 10 pM. Radioligand competition experiments were conducted in glass tubes containing 300 μL of fresh EBSS buffer with 0.2 mM sodium metabisulfite, 50 μL of diluted test compound, 100 μL of membranes (10 μg total protein). All compound dilutions were tested in triplicate and the reaction incubated for 1 h at room temperature. The reaction was terminated by filtration through Whatman GF/B filters, presoaked for 1 h in 0.5% polyethylenimine, using a Brandel R48 filtering manifold (Brandel Instruments, Gaithersburg, MD).
Name Type Language
MESPIPERONE
Common Name English
8-(4-(4-FLUOROPHENYL)-4-OXOBUTYL)-3-METHYL-1-PHENYL-1,3,8-TRIAZASPIRO(4.5)DECAN-4-ONE
Common Name English
N-METHYLSPIROPERIDOL
Common Name English
3-N-METHYLSPIPERONE
Common Name English
1,3,8-TRIAZASPIRO(4.5)DECAN-4-ONE, 8-(4-(4-FLUOROPHENYL)-4-OXOBUTYL)-3-METHYL-1-PHENYL-
Common Name English
NMSP
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID70236379
Created by admin on Sat Dec 16 14:07:13 GMT 2023 , Edited by admin on Sat Dec 16 14:07:13 GMT 2023
PRIMARY
PUBCHEM
119146
Created by admin on Sat Dec 16 14:07:13 GMT 2023 , Edited by admin on Sat Dec 16 14:07:13 GMT 2023
PRIMARY
WIKIPEDIA
N-Methylspiperone
Created by admin on Sat Dec 16 14:07:13 GMT 2023 , Edited by admin on Sat Dec 16 14:07:13 GMT 2023
PRIMARY
FDA UNII
5U54JM2T8G
Created by admin on Sat Dec 16 14:07:13 GMT 2023 , Edited by admin on Sat Dec 16 14:07:13 GMT 2023
PRIMARY
CAS
87539-19-3
Created by admin on Sat Dec 16 14:07:13 GMT 2023 , Edited by admin on Sat Dec 16 14:07:13 GMT 2023
PRIMARY